Gallardo, Analyn C.

HRN: 02-63-32  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/05/2024
08/11/2024
IV
280mg
OD
T/c Urosepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: